Skip to main content
. 2022 Aug 18;28(20):4402–4409. doi: 10.1158/1078-0432.CCR-22-1687

Table 2.

Treatment cycles and the reasons for discontinuation.

Arm A (N = 64) Arm B (N = 64)
Treatment courses, median (range) 2 (1–28) 4 (1–31)
Reasons for discontinuation
 Disease progression, n (%) 46 (71.9) 33 (51.6)
 Adverse events, n (%) 6 (9.4) 25 (39.1)
 Participants' wish, n (%) 7 (10.9) 3 (4.7)
 Death, n (%) 0 1 (1.6)
 Others, n (%) 1 (1.6) 0